Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Daniel Ahn's Talks
Daniel Ahn
Mayo Clinic Arizona
future studies with RAS inhibitors
September 1, 2026
Daniel Ahn
Mayo Clinic Arizona
00:00
--:--
zanidatamab and 2nd interim OS analysis
September 1, 2026
Share
zanidatamab and 2nd interim OS analysis
https://www.medspoke.co/channel_playlist?object_id=796&tap_id=13625
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Daniel Ahn
Mayo Clinic Arizona
zanidatamab approved in GEA cancers
August 31, 2026
Why are you reporting this TALK?
